日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Phase II Multicenter Trial of Trabectedin in Combination with Olaparib in Patients with Advanced Unresectable or Metastatic Sarcoma.

一项 II 期多中心试验,评估曲贝替定联合奥拉帕尼治疗晚期不可切除或转移性肉瘤患者的疗效

Siontis Brittany L, Rice John D, Schuetze Scott M, Rottmann Douglas, Angeles Christina V, Fox Amanda K, Zyczynski Laurie E, Hayek Salim, Robinson Steven I, Okuno Scott H, Ho Thanh P, Chugh Rashmi